Advertisement · 728 × 90
#
Hashtag
#aacr25
Advertisement · 728 × 90
Post image

The AACR Annual Meeting is the touchstone event for the cancer research community. #AACR25 convened 22,000 attendees from 85 countries to explore and expand the continuum of cancer science and medicine. Learn more in the AACR Annual Impact Report:
buff.ly/PSiw06M

1 2 0 0
Preview
bit.ly Glenn Hanna, MD, of Dana-Farber Cancer Institute

“I think this is tremendous. Now immunotherapy will be here and present for our head and neck [cancer] patients undergoing cancer resection,” said @danafarbernews.bsky.social’s Glenn Hanna, MD, in an Oncology Times article describing clinical trials presented at #ASCO25 and #AACR25. bit.ly/4qF4ID9

0 0 0 0

Honored to be included in this #SABCS25 session highlighting #AACR25 work!

Thank you to Drs. Charles Perou and Carlos Arteaga for moderating, and to AACR for organizing. Grateful as well to
Dr. Jenn Guerriero and many collaborators whose support and insight shaped this research!

2 0 0 0
Post image

Best of AACR 2025: #AACRFellows Charles M. Perou and Carlos L. Arteaga moderated an #SABCS25 educational session that featured high-impact #AACR25 presentations from Paul S. Mischel, Piro Lito, Yun Yan, and Kenichi Shimada.
@kenichi-shimada.bsky.social

2 1 0 1
Preview
First-in-class Cbl-b inhibitor GRC 65327 in solid tumors - VJOncology Mario Perro, PhD, Ichnos Glenmark Innovation, New York, NY, discusses the preclinical profile of GRC 65327, a highly selective and...

🎥 Mario Perro, PhD, highlights GRC 65327, a selective Cbl-b inhibitor:

🚀 Boosts T/NK cell activity, restores T cell function & enhances anti–PD-1 responses in solid tumor models. Favorable safety profile supports further study

🔗 buff.ly/hBycSv4

@theaacr.bsky.social #AACR25 #Oncology #ImmunoOnc

0 0 0 0
Post image

Two powerful conversations on Believe in Progress from #AACR25, Rodney and Erika McLeod share how cancer shaped their mission in youth education, and AACR Foundation President and Chairman, Stephen Ryan, reflects on advocacy. Listen to the latest episode: www.youtube.com/playlist?lis...

4 1 1 0
Post image

At the AACR Annual Meeting 2025, AACR President Dr. Lillian L. Siu became the organization's new president. Learn more about her contributions to cancer research: leadingdiscoveries.aacr.org/dr-lillian-l-siu-at-the-leading-edge-of-drug-development/ #AACR25

9 2 0 1
Video

“Let us remind the world what we have long known—that cancer research saves lives.”
#AACR25 attendees stood together and raised their voices to support cancer research. Join them and ask Congress to preserve our investment in NIH:
buff.ly/1hGcoZ2
#FundNIH

7 3 0 0
Post image

“Every voice is important.”
At #AACR25, AACR Past President Patricia LoRusso emphasized the importance of a collective response to threats to the research enterprise. Please join her in calling on Congress to reject the President’s FY26 budget and preserve NIH funding.
buff.ly/EkH5EcK

3 1 0 0
Post image

Look back at #AACR25
Tingting Zhai, PhD, receives the 2025 Cancer Prevention Research Award for Outstanding Journal Article. Learn more: buff.ly/TIeSu2X #CancerPrevention

0 0 0 0
Post image

A Big Ten CRC study, BTCRC-BRE19-409, was presented at #AACR25 by Darian Louthan at UW Carbone Cancer Center.

Congratulations to all co-authors and study teams whose hard work led to this publication!

Read more: bigtencrc.org/btcrc-bre19-...

2 1 0 1
Preview
The Future of Oncology: Multimodal Biomarkers, Liquid Biopsies, AI-Driven Precision and more at AACR | ASCO 2025 - Hurdle This year’s ASCO and AACR conferences showcased a powerful shift toward diagnostics and treatment approaches that combine biological depth with […]

#Diagnostics is no longer a test—it’s a system.

At #ASCO25 & #AACR25, multimodal tools like cfDNA fragmentomics & AI-led decision platforms took centre stage.

We’re building the infra to make these plug-and-play.

Read the full article here: 👇
hurdle.bio/blog/the-fut...

0 0 0 0
Video

At #AACR25, AACR Past President Patricia LoRusso highlighted how the President’s proposal to cut the NIH budget by nearly 40% will disrupt clinical trials and harm patients. Join her in calling on Congress to preserve the nation’s investment in biomedical research: buff.ly/5HWewe0

3 0 0 0
Preview
Carolyn Van: What Investigative Priorities Are Top of Mind for Canada - OncoDaily Carolyn Van: What Investigative Priorities Are Top of Mind for Canada / cancer, Carolyn Van, Fei-Fei Liu, OncoDaily, Oncology

It was wonderful to sit down with @drfeifeiliu.bsky.social while at @theaacr.bsky.social's #AACR25 to learn about what is top of mind for Canada. Enjoy our conversation!

oncodaily.com/blog/carolyn...
#CandidlyWithCarolyn #CancerResearch #CancerInnovation #CancerFutures #CIHR

1 1 0 0
Post image

Researchers at #AACR25 shared how AACR Project GENIE is helping uncover insights about rare cancer, early-onset cancer, colorectal cancer, and tumor-agnostic therapy that could impact patient care. Learn more on the #AACRBlog: buff.ly/36pDIFP #AACRGENIE

1 0 0 0
Post image

It was great to catch up with the #Lexogen team during the last #AACR25 and reflect on our collaboration progress!

Working on a commercial Live-seq workflow:
🔬 #FluidFM® OMNIUM subcellular biopsies
🧬 LUTHOR™ HD RNA-Seq prep
Capturing transcriptomes from <0.15 pg RNA while cells stay alive!

2 1 1 0
Post image

Researchers at #AACR25 shared how AACR Project GENIE is helping uncover insights about rare cancer, early-onset cancer, colorectal cancer, and tumor-agnostic therapy that could impact patient care. Learn more on the #AACRBlog: www.aacr.org/blog/2025/06... #AACRGENIE

3 2 0 0

Dostarlimab may eliminate the need for surgery in certain patients with dMMR #solidtumors. Presented at @theaacr.bsky.social conference #AACR25, from @cancertherapyadv.bsky.social.

bit.ly/3HGTCfx

0 0 0 0
Post image

At #AACR25, AACR Past President Patricia LoRusso highlighted remarkable recent progress against cancer and discussed how that progress is under threat. Join her in asking Congress to reject the President’s FY26 budget and preserve the nation’s investment in NIH:
www.votervoice.net/AACR/Campaig...

1 0 0 0

Honored to see our Director, Dr. Rakesh Jain, recognized for his pioneering work in intravital microscopy and the tumor microenvironment. A true visionary in cancer research!
#AACR25 #TME #IntravitalMicroscopy

0 0 0 0
Preview
Overcoming Resistance Remains a Challenge in Targeting KRAS - ILCN.org (ILCN/WCLC) Dana-Farber's Dr. Alice Shaw recently explored various combination strategies that show promise in preventing or delaying resistance in this previously undruggable space.

#AACR25 Recap: Dr. Alice Shaw highlights promising combination strategies in overcoming KRAS resistance. 🔗 Read more in ILCN: bit.ly/3T9SGmq

0 0 0 0
Post image

Learn how combining MERSCOPE Ultra™ and InSituPlex® provides a more comprehensive view of immune infiltration, tumor biology, and spatial organization within human FFPE cancer samples. 

Download our #AACR25 Poster:
hubs.ly/Q03qzRMG0

2 1 0 0
Post image

On the latest episode of Believe in Progress Podcast, recorded at #AACR25 in Chicago, we speak with two cancer patients and advocates who share how their experiences have fueled their advocacy for lifesaving cancer research. Listen here: www.youtube.com/playlist?lis... #CelebrateSurvivorship

2 0 0 0
Video

#ICYMI: AACR Past President Patricia LoRusso was among those who spoke about the importance of medical research funding at #AACR25. Learn more on the #AACRBlog: www.aacr.org/blog/2025/05...

3 0 0 0
Post image

New research presented by Dr. Giorgio Caturegli #ASCO25 justifies using radiation after chemoimmunotherapy for patients with stage III #NSCLC. #AACR25
meetings.asco.org/2025-asco-annu…
@yaleschoolofmed.bsky.social

2 0 0 0
Post image

At #AACR25, experts offered strategies to overcome the challenges of translating discoveries into new therapeutics. Learn more on the #AACRBlog: buff.ly/ovqh8Uk

1 1 0 0
Post image

At #AACR25, @vhio.bsky.social clinician-scientist Irene Braña, global PI of the BoB platform study presented promising results of #immunotherapy in solid #cancer patients stratified by underlying molecular mechanisms leading to MSI.

Fantastic collaboration within @cancercoreeurope.bsky.social

5 1 0 0
Preview
The Impact of Funding Cuts: AACR Annual Meeting 2025 Shows Why Cancer Research Matters At the AACR Annual Meeting 2025, researchers and patient advocates shared insights into the impact of NIH funding cuts on cancer research.

AACR Past President Patricia LoRusso was among those who spoke about the importance of medical research funding at #AACR25. Learn more on the #AACRBlog: buff.ly/3SXahPw #NCRM25 #UnitedByCancerResearch

4 3 0 0
Preview
AACR Annual Meeting 2025 | Cancer Today Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.

#ICYMI: Catch up with research updates, policy discussions, patient advocacy, and more news from the AACR Annual Meeting 2025, with all of Cancer Today’s coverage. www.cancertodaymag.org/cancer-talk/... #AACR25

2 1 0 0
Preview
Beamion LUNG-01 Trial Results Support Zongertinib’s Potential as a First-Line Therapy - ILCN.org (ILCN/WCLC) Dr. John V. Heymach says the latest findings suggest zongertinib may address an unmet need for patients with HER2-mutant NSCLC.

🆕 Dr. John V. Heymatch shares the latest Beamion LUNG-1 trial results at #AACR25.

🔗 Read the full recap now on #ILCN: bit.ly/3Ft5Asn

#LCSM

3 1 0 0